C12N 2501/395
Thyroid hormones
C12N2501/395 (Thyroid hormones) appears on 184 US grants and 295 published applications in this corpus.
Search patents in C12N- Granted patents
- 184
- Published applications
- 295
- Assignees
- 174
- Inventors
- 496
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 5 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 8 | 0 |
| 1998 | 12 | 0 |
| 1999 | 8 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 4 |
| 2002 | 5 | 10 |
| 2003 | 3 | 13 |
| 2004 | 1 | 4 |
| 2005 | 4 | 6 |
| 2006 | 5 | 8 |
| 2007 | 5 | 12 |
| 2008 | 2 | 5 |
| 2009 | 3 | 12 |
| 2010 | 6 | 11 |
| 2011 | 4 | 13 |
| 2012 | 6 | 13 |
| 2013 | 5 | 6 |
| 2014 | 3 | 14 |
| 2015 | 5 | 8 |
| 2016 | 6 | 13 |
| 2017 | 5 | 12 |
| 2018 | 6 | 14 |
| 2019 | 7 | 20 |
| 2020 | 10 | 14 |
| 2021 | 15 | 18 |
| 2022 | 8 | 11 |
| 2023 | 9 | 8 |
| 2024 | 5 | 17 |
| 2025 | 5 | 20 |
| 2026 | 5 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for generating oligodendrocyte progenitor cells8 Sep 2026US 12,729,368 B2Trailhead Biosystems Inc.
- Methods for reprogramming cells and uses thereof12 May 2026US 12,624,342 B2Genesis Technologies Limited
- Methods to induce terminal differentiation in stem cells by interfering with DNA replication, methods of inducing pancreatic differentiation, and differentiated cells obtained thereof21 Apr 2026US 12,605,407 B2The Trustees of Columbia University in the City of New York
- Method for producing cell aggregate including glial progenitor cells27 Jan 2026US 12,533,383 B2Keio University
- Generation of pancreatic progenitor cells and beta cells from human pluripotent stem cells6 Jan 2026US 12,516,295 B2The Penn State Research Foundation
- Composition containing extracellular matrix and matrix-bound vesicles for producing extracellular matrix and preparation method therefor24 Sep 2026US 2026/0286308 A1Hlb Cell Co., Ltd
- Culture media and conditions for in vitro expansion and/or maturation of hepatocytes24 Sep 2026US 2026/0286311 A1Satellite Biosciences, Inc.
- Use of conditioned medium derived from cultivation of mesenchymal stem cells of the umbilical cord for inducing, stimulating and promoting hair growth and regeneration9 Jul 2026US 2026/0191766 A1Cellresearch Corporation Pte. Ltd.
- Culture media and conditions for in vitro expansion and/or maturation of hepatocytes11 Jun 2026US 2026/0159813 A1Satellite Biosciences, Inc.
- Pancreatic cells for treating diabetes and methods of generating the same14 May 2026US 2026/0130949 A1Seraxis, Inc.
Most cited
By later US patents
- Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals223US 5,753,506 ACNS Stem Cell Technology, Inc. · 1998
- Mammalian neural crest stem cells206US 5,589,376 ACalifornia Institute of Technology · 1996
- Method for culturing Chinese hamster ovary cells186US 5,633,162 AGlaxo Wellcome Inc. · 1997
- Human pancreatic epithelial progenitor cells and methods of isolation and use thereof171US 6,436,704 B1Raven Biotechnologies, Inc. · 2002
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008